Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Thompson, Am J Health Syst Pharm 58 (22) 2120-2121.
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thompson, C. A.

Once-weekly erythropoiesis-stimulating protein enters market

Cheryl A. Thompson


(November 15, 2001, News). On page 2120, the first sentence of paragraph 2 should read as follows: With the additional carbohydrate side chains, darbepoetin alfa has a terminal half-life about three times longer than epoetin alfa after i.v. or s.c. administration.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Health-System Pharmacists.